Surgical treatment of small-cell bronchial carcinoma
Baudrexl, A.; Wilde, I.; Eule, H.; Dippmann, A.; Haenselt, V.; Baudrexl, L.; Bieselt, R.; Brethner, J.; Haupt, R.; Wilde, I.
Archiv für Geschwulstforschung 54(1): 61-67
1984
ISSN/ISBN: 0003-911X PMID: 6322722 Document Number: 238256
The analysis of 284 resected small-cell bronchial cancers from 4 Lung clinics has shown that these represent 11% of all resected lung cancers. The 5-year survival rate was 24%. The male-to-female ratio was 9.5: 1. Two-thirds were detected by X-ray mass screening. The majority of them (60%) were peripheral tumors. 50% of the patients had a stage Ia cancer and showed a 5-year survival of 40%! This result speaks for the primary surgical therapy even for stage I small-cell bronchial cancers, and for a 6-month screening interval of the respective risk groups. Patients with stage II or III cancers showed a 5-year survival rate of only 10%. In such cases postoperative adjuvant chemotherapy should be carried out. But such a therapy seems to be little effective in stage Ia patients.